Researchers have suggested a way of reducing the risk of infection faced by cancer patients receiving immune checkpoint inhibitor treatment.
The research, published in the journal Immunity, points to B cells being affected by the treatment, meanin...
4 months ago
A new gene-editing therapy for sickle cell disease is using CRISPR to correct the mutation behind the disease, developers have announced.
Patients are being enrolled for a US-based trial, which will seek to correct the mutation within patients’ ow...
4 months ago
